Literature DB >> 9401311

Galanin-acetylcholine interactions in rodent memory tasks and Alzheimer's disease.

M P McDonald1, J N Crawley.   

Abstract

Galanin is a 29-amino-acid neuropeptide that is widely distributed in the mammalian central nervous system. Galanin-immunoreactive cell bodies, fibres and terminals, and galanin binding sites, are located in the basal forebrain of rats, monkeys and humans. Galanin fibres hyperinnervate the surviving cholinergic cell bodies in patients with Alzheimer's disease (AD). In rats, galanin inhibits acetylcholine release and produces deficits in learning and memory. These findings suggest that overexpressed galanin may contribute to the cognitive impairments exhibited by patients with AD. This paper reviews the literature on galanin distribution and function in light of its putative role in the mnemonic deficits in patients with AD, the effects of galanin on tests of learning and memory, and preliminary experiments with galanin antagonists in animal models of AD.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9401311      PMCID: PMC1188878     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  226 in total

1.  Galanin-like immunoreactivity in hippocampal afferents in the rat, with special reference to cholinergic and noradrenergic inputs.

Authors:  T Melander; W A Staines; A Rökaeus
Journal:  Neuroscience       Date:  1986-09       Impact factor: 3.590

2.  Distribution of galanin immunoreactivity in the respiratory tract of pig, guinea pig, rat, and dog.

Authors:  A Cheung; J M Polak; F E Bauer; A Cadieux; N D Christofides; D R Springall; S R Bloom
Journal:  Thorax       Date:  1985-12       Impact factor: 9.139

3.  Galanin blocks the slow cholinergic EPSP in CA1 pyramidal neurons from ventral hippocampus.

Authors:  P Dutar; Y Lamour; R A Nicoll
Journal:  Eur J Pharmacol       Date:  1989-05-19       Impact factor: 4.432

4.  Hyperinnervation of surviving neurons of the human basal nucleus of meynert by galanin in dementias of Alzheimer's and Parkinson's disease.

Authors:  V Chan-Palay
Journal:  Adv Neurol       Date:  1990

Review 5.  Alzheimer's disease: a disorder of cortical cholinergic innervation.

Authors:  J T Coyle; D L Price; M R DeLong
Journal:  Science       Date:  1983-03-11       Impact factor: 47.728

6.  Distribution of Galanin mRNA Containing Cells and Galanin Receptor Binding Sites in Human and Rat Hypothalamus.

Authors:  C. Bonnefond; J. M. Palacios; A. Probst; G. Mengod
Journal:  Eur J Neurosci       Date:  1990       Impact factor: 3.386

7.  Effects of galanin on proinsulin mRNA and insulin biosynthesis in normal islets.

Authors:  S Lindskog; S Gregersen; K Hermansen; B Ahrén
Journal:  Regul Pept       Date:  1995-08-22

8.  Analysis of anatomical sites at which galanin impairs delayed nonmatching to sample in rats.

Authors:  J K Robinson; J N Crawley
Journal:  Behav Neurosci       Date:  1994-10       Impact factor: 1.912

9.  The human galanin receptor: ligand-binding and functional characteristics in the Bowes melanoma cell line.

Authors:  E Heuillet; Z Bouaiche; J Ménager; P Dugay; N Munoz; H Dubois; B Amiranoff; A Crespo; J Lavayre; J C Blanchard
Journal:  Eur J Pharmacol       Date:  1994-10-14       Impact factor: 4.432

10.  The distribution of dopamine-beta-hydroxylase, neuropeptide Y and galanin in locus coeruleus neurons.

Authors:  R Y Moore; E L Gustafson
Journal:  J Chem Neuroanat       Date:  1989 Mar-Apr       Impact factor: 3.052

View more
  5 in total

1.  Deficits in trace cued fear conditioning in galanin-treated rats and galanin-overexpressing transgenic mice.

Authors:  Jefferson W Kinney; Grzegorz Starosta; Andrew Holmes; Craige C Wrenn; Rebecca J Yang; Ashley P Harris; Katharine C Long; Jacqueline N Crawley
Journal:  Learn Mem       Date:  2002 Jul-Aug       Impact factor: 2.460

2.  Impairment of memory consolidation by galanin correlates with in vivo inhibition of both LTP and CREB phosphorylation.

Authors:  Jefferson W Kinney; Manuel Sanchez-Alavez; Alasdair M Barr; Jose R Criado; Jacqueline N Crawley; M Margarita Behrens; Steven J Henriksen; Tamas Bartfai
Journal:  Neurobiol Learn Mem       Date:  2009-06-14       Impact factor: 2.877

3.  Coadministration of galanin antagonist M40 with a muscarinic M1 agonist improves delayed nonmatching to position choice accuracy in rats with cholinergic lesions.

Authors:  M P McDonald; L B Willard; G L Wenk; J N Crawley
Journal:  J Neurosci       Date:  1998-07-01       Impact factor: 6.167

4.  Galanin Regulates Myocardial Mitochondrial ROS Homeostasis and Hypertrophic Remodeling Through GalR2.

Authors:  Frederic Boal; Mathieu Cinato; Andrei Timotin; Heike Münzberg; Emily Qualls-Creekmore; Solomiia Kramar; Halyna Loi; Jerome Roncalli; Sokhna Keita; Helene Tronchere; Oksana Kunduzova
Journal:  Front Pharmacol       Date:  2022-03-31       Impact factor: 5.810

5.  A 72-hour high fat diet increases transcript levels of the neuropeptide galanin in the dorsal hippocampus of the rat.

Authors:  Ling Gan; Emily England; Jeong-Yeh Yang; Natalie Toulme; Suresh Ambati; Diane L Hartzell; Richard B Meagher; Clifton A Baile
Journal:  BMC Neurosci       Date:  2015-08-11       Impact factor: 3.288

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.